Diego Fernández-Edreira

Diego Fernández-Edreira

Auto-generated profile, based on publicly available information

Diego Fernández-Edreira

Machine Learning in Life Sciences Laboratory, Department of Computer Science and Information Technologies, Universidade da Coruña (CITIC), A Coruña, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Expert Systems with Applications
Verified
Journal Article
Open access
DFDiego Fernández-Edreira
Diego Fernández-Edreira
JLJose Liñares-Blanco
Jose Liñares-Blanco
Carlos Fernandez-LozanoCarlos Fernandez-Lozano
Carlos Fernandez-Lozano

11 June 2025 in PeerJ
Verified
Journal Article
Open access
PDF file
LLLaura Isabel Sinisterra Loaiza
Laura Isabel Sinisterra Loaiza
DFDiego Fernández-Edreira
Diego Fernández-Edreira
JLJose Liñares-Blanco
Jose Liñares-Blanco
ACAlberto Cepeda
Alberto Cepeda
ACAlejandra Cardelle-Cobas
Alejandra Cardelle-Cobas
Carlos Fernandez-LozanoCarlos Fernandez-Lozano
Carlos Fernandez-Lozano
Background: Metabolic syndrome (MS) and type 2 diabetes (T2D) are metabolically related diseases with rising global prevalence and increasingly evident links to the intestinal microbiota. Research suggests that imbalances in microbiota composition may play a crucial role in their pathogenesis. Specific population cohorts, such as the one in Galicia, Spain, offer the opportunity to analyze microbiota patterns within a distinct geographical and genetic context. This study was performed to investigate the relationship between the intestinal microbiota and MS and T2D. Methods: A cohort of 79 volunteers was analyzed over a 2-year study period. Recruitment posed significant challenges because of strict inclusion criteria (918PTE0540; PCI2018-093284), which required participants to be free from chronic medications and have a moderate to high risk of developing T2D. Volunteers were classified based on their serum glucose levels, body mass index, and the presence or absence of MS. To analyze the microbiota composition, amplicon sequencing of 16S rRNA genes was performed on stool samples. Alpha diversity was assessed using the Chao and Shannon indices, while beta diversity was evaluated using permutational analysis of variance with Bray–Curtis and Chao distances. Differential abundance analysis was conducted using the LinDA method. Results: In patients with MS, we observed a higher Firmicutes/Bacteroidetes ratio and an increased prevalence of Blautia compared to healthy patients. than in healthy individuals. Other enriched taxa in patients with MS included Tyzerella, Streptococcus, and Ruminococcus callidus. In patients with T2D, we observed a higher Bacteroidetes/Firmicutes ratio and a decrease in the phylum Actinobacteria compared with healthy individuals. Taxa such as Dorea, Prevotella, Dialister invisus, Fusicatenibacter, and Coprococcus were associated with T2D, while beneficial taxa such as Eubacterium, Ligilactobacillus, and Acidaminococcus were more prevalent in healthy or prediabetic individuals. Conclusions: This study reveals notable differences in the intestinal microbiota composition among patients with MS and T2D. Changes in microbial composition, particularly the Firmicutes/Bacteroidetes ratio, may serve as indicators of underlying pathology. At more specific taxonomic levels, several enriched taxa were identified in patients with MS, including Blautia, Tyzzerella, Dorea, Streptococcus, and Ruminococcus callidus. Additionally, species such as Dorea longicatena and Dialister invisus were enriched in prediabetic and diabetic patients, whereas beneficial genera (Eubacterium, Acidaminococcus, Bifidobacterium, and Ligilactobacillus) were more prevalent in healthy and prediabetic individuals than in those with T2D.

30 November 2023 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
DFDiego Fernández-Edreira
Diego Fernández-Edreira
JLJose Liñares-Blanco
Jose Liñares-Blanco
PVPatricia V.-Del-Río
Patricia V.-Del-Río
Carlos Fernandez-LozanoCarlos Fernandez-Lozano
Carlos Fernandez-Lozano
This study aimed to develop a robust classification scheme for stratifying patients based on vaginal microbiome. By employing consensus clustering analysis, we identified four distinct clusters using a cohort that includes individuals diagnosed with Bacterial Vaginosis (BV) as well as control participants, each characterized by unique patterns of microbiome species abundances. Notably, the consistent distribution of these clusters was observed across multiple external cohorts, such as SRA022855, SRA051298, PRJNA208535, PRJNA797778, and PRJNA302078 obtained from public repositories, demonstrating the generalizability of our findings. We further trained an elastic net model to predict these clusters, and its performance was evaluated in various external cohorts. Moreover, we developed VIBES, a user-friendly R package that encapsulates the model for convenient implementation and enables easy predictions on new data. Remarkably, we explored the applicability of this new classification scheme in providing valuable insights into disease progression, treatment response, and potential clinical outcomes in BV patients. Specifically, we demonstrated that the combined output of VIBES and VALENCIA scores could effectively predict the response to metronidazole antibiotic treatment in BV patients. Therefore, this study's outcomes contribute to our understanding of BV heterogeneity and lay the groundwork for personalized approaches to BV management and treatment selection.

27 August 2020 in Proceedings
Verified
Conference Paper
Open access
PDF file
DFDiego Fernández-Edreira
Diego Fernández-Edreira
JLJose Liñares-Blanco
Jose Liñares-Blanco
Carlos Fernandez-LozanoCarlos Fernandez-Lozano
Carlos Fernandez-Lozano
Previous works have reported different bacterial strains and genera as the cause of different clinical pathological conditions. In our approach, using the fecal metagenomic profiles of newborns, a machine learning-based model was generated capable of discerning between patients affected by type I diabetes and controls. Furthermore, a random forest algorithm achieved a 0.915 in AUROC. The automation of processes and support to clinical decision making under metagenomic variables of interest may result in lower experimental costs in the diagnosis of complex diseases of high prevalence worldwide.

1 January 2025 in Drug Repurposing
Verified
Journal Article
Open access
PDF file
Hugo A. L. FilipeHugo A. L. Filipe
Hugo A. L. Filipe
ACAntónio Costa
António Costa
André F. MoreiraAndré F. Moreira
André F. Moreira
SMSónia Miguel
Sónia Miguel
FRFátima Roque
Fátima Roque
IFIván Rarís Filgueira
Iván Rarís Filgueira
The development of new drugs is hindered by high failure rates, substantial costs, and prolonged timelines, highlighting the importance of drug repurposing (or drug repositioning) as a key strategy to identify new therapeutic applications for existing drugs. Despite its potential, collaboration within the SUDOE space, concerning Portugal, Spain, and France, remains limited, as evidenced by a bibliometric analysis that reveals their relatively modest contribution to global drug repurposing research in comparison to leading countries, such as China, USA, and UK. The RePo-SUDOE project aims to address this gap by bringing together diverse partners to advance drug repurposing technologies and enhance the region’s competitiveness in this field. The project includes three key objectives: (i) raising awareness and understanding of drug repurposing technologies, positioning SUDOE’s R&D centers as leaders in European research; (ii) fostering multidisciplinary collaboration and identifying opportunities for innovative drug repurposing initiatives across the SUDOE space through the establishment of a transnational network with a key focus of developing methodologies for drug repurposing for cancer treatment; (iii) creating a prototype of a three-dimensional visualization room for biological systems with virtual and augmented reality technologies to explore drug–target interactions, engaging STEAM students and researchers in immersive learning. The RePo-SUDOE project brings together diverse partners from the SUDOE space to collaborate on drug repurposing, making scientific information more accessible, and using advanced visualization technologies to strengthen the field in this geographic region.

15 May 2025
Verified
Book Chapter
Closed access
PDF file
DFDiego Fernández-Edreira
Diego Fernández-Edreira
JLJose Liñares-Blanco
Jose Liñares-Blanco
Carlos Fernandez-LozanoCarlos Fernandez-Lozano
Carlos Fernandez-Lozano